Nanopatterned muscle cell patches for enhanced myogenesis and dystrophin expression in a mouse model of muscular dystrophy

Biomaterials

Volumn 35, Issue 5, 2014, Pages 1478-1486

  Yang, Hee Seok ^a,b   Ieronimakis, Nicholas ^c   Tsui, Jonathan H ^a   Kim, Hong Nam ^d   Suh, Kahp Yang ^d   Reyes, Morayma ^c   Kim, Deok Ho ^a,c  

^a University of Washington   (United States)

^b Dankook University   (South Korea)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Seoul National University   (South Korea)

Author keywords

Muscle tissue engineering; Muscular dystrophy; Myogenesis; Nanotopography; Poly(lactic co glycolic acid)

Indexed keywords

MUSCLE TISSUES; MUSCULAR DYSTROPHY; MYOGENESIS; NANOTOPOGRAPHIES; POLY LACTIC-CO-GLYCOLIC ACID;

BIOMIMETIC PROCESSES; CELLS; MAMMALS; NANOTECHNOLOGY; TISSUE ENGINEERING;

MUSCLE;

DYSTROPHIN; MYOD PROTEIN; MYOGENIC FACTOR 5; MYOGENIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADATION; BIOMIMETICS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ENGRAFTMENT; EXTRACELLULAR MATRIX; FEASIBILITY STUDY; GLASS TRANSITION TEMPERATURE; IN VIVO STUDY; MALE; MONONUCLEAR CELL; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MYOTUBE; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; UPREGULATION;

MUS;

MUSCLE TISSUE ENGINEERING; MUSCULAR DYSTROPHY; MYOGENESIS; NANOTOPOGRAPHY; POLY(LACTIC-CO-GLYCOLIC ACID);

ANIMALS; DISEASE MODELS, ANIMAL; DYSTROPHIN; LACTIC ACID; MALE; MICE; MICROSCOPY, ATOMIC FORCE; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NANOTECHNOLOGY; POLYGLYCOLIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84890181667     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.067     Document Type: Article

References (63)

1. Collins C.A., Partridge T.A. Self-renewal of the adult skeletal muscle satellite cell. Cell Cycle 2005, 4:1338-1341.
2. Bach A.D., Beier J.P., Stern-Staeter J., Horch R.E. Skeletal muscle tissue engineering. JCell Mol Med 2004, 8:413-422.
3. Bushby K., Finkel R., Birnkrant D.J., Case L.E., Clemens P.R., Cripe L., et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010, 9:177-189.
4. Mendell J.R., Kissel J.T., Amato A.A., King W., Signore L., Prior T.W., et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. NEngl J Med 1995, 333:832-838.
5. Kim D.H., Lipke E.A., Kim P., Cheong R., Thompson S., Delannoy M., et al. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc Natl Acad Sci U S A 2010, 107:565-570.
6. Kim D.H., Kshitiz, Smith R.R., Kim P., Ahn E.H., Kim H.N., et al. Nanopatterned cardiac cell patches promote stem cell niche formation and myocardial regeneration. Integr Biol 2012, 4:1019-1033.
7. Barber J.G., Handorf A.M., Allee T.J., Li W.J. Braided nanofibrous scaffold for tendon and ligament tissue engineering. Tissue Eng Part A 2011, 11-12:1265-1274.
8. Vunjak-Novakovic G., Altman G., Horan R., Kaplan D.L. Tissue engineering of ligaments. Annu Rev Biomed Eng 2004, 6:131-156.
9. Silva G.A., Czeisler C., Niece K.L., Beniash E., Harrington D.A., Kessler J.A., et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004, 303:1352-1355.
10. Wittmer C.R., Claudepierre T., Reber M., Wiedemann P., Garlick J.A., Kaplan D., et al. Multifunctionalized electrospun silk fibers promote axon regeneration in central nervous system. Adv Funct Mater 2011, 21:4202.
11. Gillies A.R., Lieber R.L. Structure and function of the skeletal muscle extracellular matrix. Muscle Nerve 2011, 44:318-331.
12. Trotter J.A., Purslow P.P. Functional morphology of the endomysium in series fibered muscles. JMorphol 1992, 212:109-122.
13. Siegel A.L., Atchison K., Fisher K.E., Davis G.E., Cornelison D.D. 3D timelapse analysis of muscle satellite cell motility. Stem Cells 2009, 27:2527-2538.
14. Calve S., Odelberg S.J., Simon H.G. Atransitional extracellular matrix instructs cell behavior during muscle regeneration. Dev Biol 2010, 344:259-271.
15. Ieronimakis N., Balasundaram G., Rainey S., Srirangam K., Yablonka-Reuveni Z., Reyes M. Absence of CD34 on murine skeletal muscle satellite cells marks a reversible state of activation during acute injury. PLoS One 2010, 5:e10920.
16. Ieronimakis N., Balasundaram G., Reyes M. Direct isolation, culture and transplant of mouse skeletal muscle derived endothelial cells with angiogenic potential. PLoS One 2008, 3:e0001753.
17. Kelly R., Alonso S., Tajbakhsh S., Cossu G., Buckingham M. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. JCell Biol 1995, 129:383-396.
18. Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 1997, 407:313-319.
19. Xing Y., Lv A., Wang L., Yan X., Zhao W., Cao F. Engineered myocardial tissues constructed invivo using cardiomyocyte-like cells derived from bone marrow mesenchymal stem cells in rats. JBiomed Sci 2012, 19:6.
20. Stout D.A., Basu B., Webster T.J. Poly(lactic-co-glycolic acid): carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater 2011, 7:3101-3112.
21. Middleton J.C., Tipton A.J. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 2000, 21:2335-2346.
22. Cai Q., Shi G., Bei J., Wang S. Enzymatic degradation behavior and mechanism of poly(lactide-co-glycolide) foams by trypsin. Biomaterials 2003, 24:629-638.
23. Gunatillake P.A., Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 2003, 5:1-16.
24. Paoni N.F., Peale F., Wang F., Errett-Baroncini C., Steinmetz H., Toy K., et al. Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice. Physiol Genomics 2002, 11:263-272.
25. Kim D.H., Kim P., Song I., Cha J.M., Lee S.H., Kim B., et al. Guided three-dimensional growth of functional cardiomyocytes on polyethylene glycol nanostructures. Langmuir 2006, 22:5419-5426.
26. Darabi R., Gehlbach K., Bachoo R.M., Kamath S., Osawa M., Kamm K.E., et al. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 2008, 14:134-143.
27. Mizuno Y., Chang H., Umeda K., Niwa A., Iwasa T., Awaya T., et al. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J 2010, 24:2245-2253.
28. Sherwood R.I., Christensen J.L., Conboy I.M., Conboy M.J., Rando T.A., Weissman I.L., et al. Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 2004, 119:543-554.
29. Asakura A., Hirai H., Kablar B., Morita S., Ishibashi J., Piras B.A., et al. Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle. Proc Natl Acad Sci U S A 2007, 104:16552-16557.
30. Montarras D., Morgan J., Collins C., Relaix F., Zaffran S., Cumano A., et al. Direct isolation of satellite cells for skeletal muscle regeneration. Science 2005, 309:2064-2067.
31. Halevy O., Piestun Y., Allouh M.Z., Rosser B.W., Rinkevich Y., Reshef R., et al. Pattern of Pax7 expression during myogenesis in the posthatch chicken establishes a model for satellite cell differentiation and renewal. Dev Dyn 2004, 231:489-502.
32. Christov C., Chretien F., Abou-Khalil R., Bassez G., Vallet G., Authier F.J., et al. Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell 2007, 18:1397-1409.
33. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. Abiomarker that identifies senescent human cells in culture and in aging skin invivo. Proc Natl Acad Sci U S A 1995, 92:9363-9367.
34. Cohen D.J., Morfino R.C., Maharbiz M.M. Amodified consumer inkjet for spatiotemporal control of gene expression. PLoS One 2009, 4.
35. Beauchamp J.R., Heslop L., Yu D.S., Tajbakhsh S., Kelly R.G., Wernig A., et al. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. JCell Biol 2000, 151:1221-1234.
36. Day K., Paterson B., Yablonka-Reuveni Z. Adistinct profile of myogenic regulatory factor detection within Pax7+ cells at S phase supports a unique role of Myf5 during posthatch chicken myogenesis. Dev Dyn 2009, 238:1001-1009.
37. Megeney L.A., Kablar B., Garrett K., Anderson J.E., Rudnicki M.A. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 1996, 10:1173-1183.
38. Cornelison D.D., Wold B.J. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol 1997, 191:270-283.
39. Zammit P.S., Relaix F., Nagata Y., Ruiz A.P., Collins C.A., Partridge T.A., et al. Pax7 and myogenic progression in skeletal muscle satellite cells. JCell Sci 2006, 119:1824-1832.
40. Bulfield G., Siller W.G., Wight P.A., Moore K.J. Xchromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 1984, 81:1189-1192.
41. White R.B., Bierinx A.S., Gnocchi V.F., Zammit P.S. Dynamics of muscle fibre growth during postnatal mouse development. BMC Dev Biol 2010, 10:21.
42. Hwang S.Y., Kwon K.W., Jang K.J., Park M.C., Lee J.S., Suh K.Y. Adhesion assays of endothelial cells on nanopatterned surfaces within a microfluidic channel. Anal Chem 2010, 82:3016-3022.
43. Kim D.H., Han K., Gupta K., Kwon K.W., Suh K.Y., Levchenko A. Mechanosensitivity of fibroblast cell shape and movement to anisotropic substratum topography gradients. Biomaterials 2009, 30:5433-5444.
44. Kim D.H., Seo C.H., Han K., Kwon K.W., Levchenko A., Suh K.Y. Guided cell migration on microtextured substrates with variable local density and anisotropy. Adv Funct Mater 2009, 19:1579-1586.
45. Choi S.J., Kim H.N., Bae W.G., Suh K.Y. Modulus- and surface energy-tunable ultraviolet-curable polyurethane acrylate: properties and applications. JMater Chem 2011, 21:14325-14335.
46. Wang P.Y., Yu H.T., Tsai W.B. Modulation of alignment and differentiation of skeletal myoblasts by submicron ridges/grooves surface structure. Biotechnol Bioeng 2010, 106:285-294.
47. Teixeira A.I., Abrams G.A., Bertics P.J., Murphy C.J., Nealey P.F. Epithelial contact guidance on well-defined micro- and nanostructured substrates. JCell Sci 2003, 116:1881-1892.
48. Vogel V., Sheetz M. Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol 2006, 7:265-275.
49. Henry M.D., Campbell K.P. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol 1996, 8:625-631.
50. Ervasti J.M., Ohlendieck K., Kahl S.D., Gaver M.G., Campbell K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 1990, 345:315-319.
51. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin - the protein product of the Duchenne muscular-dystrophy locus. Cell 1987, 51:919-928.
52. Monaco A.P., Neve R.L., Collettifeener C., Bertelson C.J., Kurnit D.M., Kunkel L.M. Isolation of candidate Cdnas for portions of the Duchenne muscular-dystrophy gene. Nature 1986, 323:646-650.
53. Grady R.M., Teng H.B., Nichol M.C., Cunningham J.C., Wilkinson R.S., Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 1997, 90:729-738.
54. Pastoret C., Sebille A. mdx mice show progressive weakness and muscle deterioration with age. JNeurol Sci 1995, 129:97-105.
55. Salimena M.C., Lagrota-Candido J., Quirico-Santos T. Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice. Histochem Cell Biol 2004, 122:435-444.
56. Tanabe Y., Esaki K., Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol 1986, 69:91-95.
57. Cullen M.J., Jaros E. Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy. Acta Neuropathol 1988, 77:69-81.
58. Grounds M.D., Radley H.G., Lynch G.S., Nagaraju K., De Luca A. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis 2008, 31:1-19.
59. Chamberlain J.S. Dystrophin levels required for genetic correction of Duchenne muscular dystrophy. Basic Appl Myol 1997, 7:257-265.
60. Koning M., Harmsen M.C., van Luyn M.J., Werker P.M. Current opportunities and challenges in skeletal muscle tissue engineering. J Tissue Eng Regen Med 2009, 3:407-415.
61. Klumpp D., Horch R.E., Kneser U., Beier J.P. Engineering skeletal muscle tissue-new perspectives in vitro and in vivo. J Cell Mol Med 2010, 14:2622-2629.
62. Meregalli M., Farini A., Parolini D., Maciotta S., Torrente Y. Stem cell therapies to treat muscular dystrophy: progress to date. BioDrugs 2010, 24:237-247.
63. Scime A., Caron A.Z., Grenier G. Advances in myogenic cell transplantation and skeletal muscle tissue engineering. Front Biosci 2009, 14:3012-3023.